Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Novo Nordisk

3 'Strong Buy' Dividend Stocks That Are Beating the Market

Here are three top-rated dividend stocks that have outperformed the S&P 500 in the past month, despite a tough environment for equities.

Barchart · Nov 1, 2023

Warning as patients hospitalised after taking fake Ozempic weight-loss drug

Hundreds of fake Ozempic jabs from the black market have been seied by the regulator

The Independent UK · Oct 27, 2023

3 Top-Rated Growth Stocks To Buy on Every Dip

Growth stocks are down, but don't count them out. Here are three top-rated names worth scooping up when the market pulls back.

Barchart · Oct 24, 2023

From analysis to the latest developments in health,
read the most diverse news in one place.

Fears over black market weight loss drugs as people left seriously ill from counterfeit Ozempic

Austria’s criminal investigation service warned on Monday that fake injection pens may still be in circulation

The Independent UK · Oct 24, 2023

Aust shares close a smidge higher to extend win streak

The local share market has technically extended its winning streak to six days, with seven of the ASX's 11 sectors finishing in the green.

AAP · Oct 12, 2023

Wall Street is now betting against restaurant stocks because of Novo Nordisk’s Ozempic and high interest rates

Short positions on companies such as McDonald’s and Starbucks have increased in the last month, and weight loss drugs are part of the reason why.

Fortune · Oct 10, 2023

Rare Ozempic side effects emerging

Though side effects from Ozempic are rare, as usage rises some side effects are becoming more apparent

Salon · Oct 8, 2023

Read news from The Economist, FT, and more,
with one subscription

Warning over ‘severe’ weight-loss jab side effects

Semaglutide and liraglutide are sold under the brand names Wegovy, Ozempic, Rybelsus and Saxenda and are manufactured by Novo Nordisk

The Independent UK · Oct 5, 2023

Weight-loss jabs linked to ‘severe’ stomach problems – study

Researchers said instances were ‘rare’ but hundreds of thousands of people could still be affected due to the drugs’ popularity globally.

The Independent UK · Oct 5, 2023

Weight loss-aiding drugs Ozempic and Wegovy are dampening food sales, top Walmart exec says

The drugs, although not officially approved for use in weight loss, have been touted as a “miracle” treatments for obesity.

Fortune · Oct 5, 2023

Weight-loss drugs like Ozempic have so much promise a major bank is telling investors to short junk food stocks

Barclays strategists expect "disruption into a number of industries," thanks to drugs like Novo Nordisk's Ozempic and Wegovy.

Fortune · Oct 4, 2023

Wegovy weight-loss jab 'significantly' improves blood sugar in diabetics

Hailed as potential ‘game changer’ in tackling obesity, Semaglutide can also help those with type 2 diabetes

The Independent UK · Oct 3, 2023

Weight loss jab ‘significantly’ improves blood sugar in diabetics, study finds

Researchers said semaglutide’s effectiveness in treating type 2 diabetes has been shown in some trials, but long-term data is ‘lacking’.

The Independent UK · Oct 2, 2023

Ozempic and Wegovy ‘significantly’ improve blood sugar and weight for the long-term, new study suggests

The study represents the first long-term, large-scale, real-world trial of the blockbuster drug, researchers said.

Fortune · Oct 2, 2023

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK · Sep 20, 2023

Denmark's Novo Nordisk and South Africa's Aspen sign a deal to produce insulin for African patients

Danish pharmaceutical company Novo Nordisk has signed a deal with South Africa’s Aspen Pharmacare to produce human insulin specifically for diabetes patients in Africa where there is a dire need for the life-saving treatment

StockNews.com · Sep 19, 2023

3 Biotechs with Massive Growth Potential

These three biotech stocks have massive growth opportunities on the horizon, and could add a huge boost to any portfolio. They play in some of the most in demand markets on the planet, and have track records of finding ways to introduce products into those markets to capture big profits.…

The Guardian - UK · Sep 9, 2023

Wegovy: the slimming drug that keeps Denmark’s economy growing

Novo Nordisk, the maker of the blockbuster obesity injection, has singlehandedly saved the country from recession

Al Jazeera · Sep 7, 2023

Ozempic, weight-loss ‘wonder drug’, under scrutiny amid suicide risk claims

Ozempic has not shown increased risk of suicidal ideation in trials, but some users say it harmed their mental health.

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation · Sep 6, 2023

Wegovy has arrived in the UK: the story of the weight-loss jab so far

In February 2021, The Conversation reported on a trial for a new weight-loss drug, called semaglutide, that was being hailed in the media as a “gamechanger”. Gamechanger is a word used far too often by journalists to describe things that are, frankly, mundane. This time, though, the word seems apt.

Fortune · Sep 5, 2023

Novo Nordisk beats LVMH to become Europe’s most valuable company after it takes its ‘miracle’ weight loss drug Wegovy to the U.K.

The Danish pharma giant overtook French luxury conglomerate LVMH as the most valuable European company, which held the title since 2021.

France 24 · Sep 5, 2023

Danish pharma group becomes Europe's most valuable firm after UK weight loss drug launch

Danish drugmaker Novo Nordisk is now Europe's largest company in market capitalisation, ahead of French luxury giant LVMH. This follows the UK launch of Wegovy, a weight loss drug that cuts appetite and cravings. Tens of thousands of people have already signed up to waiting lists for the treatment. Also…

The Guardian - UK · Sep 5, 2023

Wegovy maker Novo Nordisk becomes Europe’s most valuable firm

Launch of weight-loss drug in UK helps Danish firm to market value of $428bn

The Independent UK · Sep 4, 2023

How does Wegovy work? The ‘game changing’ weight loss drug beloved by Hollywood

Ministers have announced plans which could see tens of thousands given access to new weight-loss drug

Evening Standard · Sep 4, 2023

Wegovy weight-loss jab to launch in the UK

The drug is in short supply but a proportion has been allocated to specialist NHS services

Salon · Aug 31, 2023

The history of weight loss drugs

"It is no wonder demand for weight-loss drugs continues to soar"

1 … 24 25 26 27

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.